114¦~«×¬y·P¬Ì­]/·s«a¬Ì­]±µºØ°T®§¤½§i

 


¤@. ¬y·P¬Ì­]±µºØ¨Æ¶µ»¡©ú

(¤@)          ¹ê¬I´Á¶¡

1.     ²Ä¤@¶¥¬q(114.10.01°_)

¶¥¬q¶¶§Ç

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

²Ä¤@¶¥¬q

 

114.10.01°_¦Ü¬Ì­]¥ÎÁj

65·³¥H¤WªøªÌ

(¥Á48¦~¥H«e¥X¥Í)

1.  °·«O¥d

2.  ¨­¤ÀÃÒ

150¤¸

55-64·³­ì¦í¥Á

1.°·«O¥d

2.¨­¤ÀÃÒ

3.¤áÄyÁÃ¥»©Î¤á¤f¦Wï

150¤¸

¥¥°ü

1.°·«O¥d

2.¨­¤ÀÃÒ

3.¥¥°ü°·±d¤â¥U

150¤¸

Â卯¤Î½Ã¥Í¨¾¬Ì¬ÛÃö¤H­û

1.  °·«O¥d

2.  ¨­¤ÀÃÒ

3.  Â卯°õ·Ó

150¤¸

º¡6­Ó¤ë¥H¤W¦Ü°ê¤p¤J¾Ç«e¥®¨à

1.°·«O¥d

2.¨àµ£°·±d¤â¥U

3.®aªø¦P·N®Ñ

150¤¸

¥®¨à¶é¦«¨|¤H­û¡B¦«¨|¾÷ºc±M·~¤H­û¤Î©~®a¦«¨|¤H­û(«O¥À)

1.  °·«O¥d

2.  ¥®«OÃҩΫO¥ÀÃÒ

150¤¸

°ª­·ÀIºC©Ê¯f¤H

1.°·«O¥d

2.¨­¤ÀÃÒ

3.¬ÛÃöÃÒ©ú¤å¥ó(³B¤èºà¡B¶EÂ_®Ñ)

150¤¸

¨u¨£¯e¯f±wªÌ

1. °·«O¥d

2. ¨­¤ÀÃÒ

3. ¬ÛÃöÃÒ©ú

150¤¸

­«¤j¶Ë¯f±wªÌ

1. °·«O¥d

2. ¨­¤ÀÃÒ

3. ­«¤j¶Ë¯fÃÒ©ú

150¤¸

°ê¤p¡B°ê¤¤¡B°ª¤¤¡B°ªÂ¾¡B¤­±M¤@¦Ü¤T¦~¯Å¾Ç¥Íµ¥

1.°·«O¥d

2.¸É±µºØ³qª¾®Ñ(¾Ç®Õ»\³¹)

3.±Ð¨|³¡¶}¥ß¤§¾Ç¥Í¨­¤ÀÃÒ©ú¬ÛÃö¤å¥ó

200¤¸

6­Ó¤ë¤ºÀ¦¨à¤§¤÷¥À

1.°·«O¥d

2.¨­¤ÀÃÒ

3.À¦¨à¥X¥ÍÃÒ©ú

150¤¸

¸V¯b¬ÛÃö¤Î°Êª«¨¾¬Ì¤H­û

1.  °·«O¥d

¤u§@ÃÒ

 

¦Û¶O¬Ì­]

±ý¦Û¶O±µºØ¤§¥Á²³

1. °·«O¥d

2. ¨­¤ÀÃÒ

¨Ìªù¶E¹ê»Ú¦¬¶O

2.     ²Ä¤G¶¥¬q(114.11.01°_)

¶¥¬q¶¶§Ç

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

²Ä¤G¶¥¬q

114.11.01°_¦Ü¬Ì­]¥ÎÁj

50-64·³¥H¤WµL°ª­·ÀIºC©Ê¯f¦¨¤H

1.°·«O¥d¡B¨­¤ÀÃÒ

150¤¸

 

¤G. ¤¤©MªÀ°Ï±µºØ¯¸¸ê°T(65·³¥H¤W¦¨¤H¡A§K¦¬¶O)¡C

¤T. ¦¨¤H¬y·P¬Ì­]¨Ö©ó¤@¯ëªù¶E¶i¦æ±µºØªA°È

(!!!¦Û10/3©]¶E°_¦Ü¬Ì­]¥ÎÁj!!!)

¥|. °Ñ¦Ò¸ê®Æ

(¤@)          °ª­·ÀIºC©Ê¯f¯e¯f¥N½X¤@Äýªí

(¤G)          ¨u¨£¯e¯f¤ÀÃþ§Ç¸¹·JÁ`ªí

(¤T)          ¬Ì­]±µºØ¶·ª¾

 


¤@. ¬y·P¬Ì­]±µºØ¨Æ¶µ»¡©ú

(¤@)          ¹ê¬I´Á¶¡

¥»°|°t¦X¬F©²¬Fµ¦¡A¦Û114.10.01°_¶}©ñ±µºØ¬y·P/·s«a¬Ì­]¡A¨Ì¬Fµ¦³W¹º¤À¨â¶¥¬q¶}©ñ¡C

¥¥²£°ü½Ð¦Ü°ü²£¬ìªù¶E¸gÂå®vµû¦ô«á±µºØ¡A¥t°·¨àªù¶E©P¤­¤£´£¨Ñ¤½¶O¬y·P¬Ì­]±µºØªA°È¡A½Ð¤Å±¾¸¹¡C

¦¬¶O¶µ¥Ø¡G¤W¡B¤U¤Èªù¶E150/¤¸¡B©]¶¡ªù¶E200/¤¸

1.     °·¨àªù¶E±µºØ®É¬q(10/4°_¦­¶E)

°·¨àªù¶E

¶g¤@

¶g¤G

¶g¤T

¶g¥|

¶g¤­

¶g¤»

¤W¤È¶E

¢½

¤U¤È¶E

¢½

¢½

¢½

¢½

¤£±µºØ¬y·P¬Ì­]

 

(¤G)          ±µºØª`·N¨Æ¶µ

1.     Âå°|±µºØ¤½¶O¬y·P¬Ì­]¡A±N¨Ì¨­¤À§O°u¦¬±¾¸¹¶O¤Î±µºØ³B¸m¶O¡C

2.     ºô¸ô¹w¬ù¸¹½X¤£¥Nªí²{³õ±µºØ¶¶§Ç¡A½Ð¨Ì²{³õ¸¹½XµP¤Î¤u§@¤H­û¤Þ¾É¬°·Ç¡C

3.     ¬I¥´·í¤Ñ½Ð°È¥²Äâ±a°·«O¥d¤Î¬ÛÃöÃÒ¥ó¡A¥¼Äâ±aªÌ¤£¥i¬I¥´¡C

4.     ªì¶E½Ð°È¥²Äâ±a°·«O¥d¤Î¨­¤ÀÃÒ¡C

5.     ¿Ô¸ß±M½u¡G

l  °·±d¿Ô¸ß±M½u¡G(02)2249-0088Âà1112

l  ÃĪ«¿Ô¸ß±M½u¡G(02)2248-9211

l  ¨ä¥L¿Ô¸ß±M½u¡G(02)2249-0088Âà1080-1082

 

¤G. ¤¤©M°ÏªÀ°Ï±µºØ¯¸¸ê°T(65·³¥H¤W¦¨¤H¡A§K¦¬¶O)

(¤@)          ªA°È®É¶¡¡G½Ð¨Ì¦U¨½¦w±Æ®É¬q«e©¹¬I¥´

¤é´Á

¦aÂI

¦a§}

ªA°È®É¶¡

10/15(¤T)

¤[®õ®L«Â¦iªÀ°Ï¤jÆU

«n¤s¸ô180¸¹

0800-0930

10/15(¤T)

¼q¤l§ÀÅbÄÖ¥æ½Ë¤¤¤ß

¼q¬üµó6«Ñ3¸¹1¼Ó

1000-1130

10/16(¥|)

¨q¤s¤½¶é²D«F

¦Û¥ß¸ô15«Ñ12¸¹

0830-1000

10/16(¥|)

¨q¤¯¨½¿ì¤½«Ç

¤j«iµó43«Ñ8¸¹1¼Ó

1030-1200

10/17(¤­)

º~¬ÓSuperªÀ°Ï

¤¤¤s¸ô¤G¬q299¸¹

1300-1430

10/18(¤»)

ÀA¤¤¥«¥Á¬¡°Ê¤¤¤ß

¶ê³q¸ô294«Ñ13¸¹

0800-0930

10/18(¤»)

¦ÇüŨ½¶°·|©Ò

­û¤s¸ô26¸¹

1000-1130

10/18(¤»)

´º¥»¨½¶°·|©Ò

´º·sµó423«Ñ5¸¹®Ç

0800-0930

10/18(¤»)

¤C¦w¶°·|©Ò

¦w¼Ö¸ô143«Ñ3¸¹

1000-1130

10/18(¤»)

ªL¤ó¤½ÆU

¤¤©M¸ô350«Ñ8§Ë1¤§2¸¹1¼Ó

1400-1600

10/18(¤»)

­¸¾m¥«¥Á¬¡°Ê¤¤¤ß

©¾§µµó48¸¹2¼Ó

1330-1630

10/18(¤»)

¥þÁp·s¥Í©±

·s¥Íµó255¸¹

1730-2030

10/19(¤é)

¨q¤s¥«¥Á¬¡°Ê¤¤¤ß

´º¥­¸ô64«Ñ13§Ë2¸¹

0830-1000

10/19(¤é)

±R«n¥«¥Á¬¡°Ê¤¤¤ß

´º·sµó496«Ñ26§Ë2¸¹

1030-1200

10/19(¤é)

´º«n¨½¿ì¤½«Ç¼Ó¤U

´º·sµó467«Ñ25¸¹1¼Ó

0830-1000

10/19(¤é)

´ººÖ¥«¥Á¬¡°Ê¤¤¤ß

©M¥­µó164«Ñ2¸¹

1030-1200

10/19(¤é)

¦wÁJ¥«¥Á¬¡°Ê¤¤¤ß

­û¤s¸ô294«Ñ7¸¹1¼Ó

1330-1630

10/19(¤é)

¨q®p¥«¥Á¬¡°Ê¤¤¤ß

´º¼wµó25¸¹

1330-1630

10/25(¤»)

ºÖ¯u¨½¶°·|©Ò

¤¤¤s¸ô¤G¬q312«Ñ33§Ë29¸¹®Ç

1330-1500

10/25(¤»)

ºÖ©M¥«¥Á¬¡°Ê¤¤¤ß

¤¤¤s¸ô¤G¬q131«Ñ6¸¹

1530-1700

10/25(¤»)

ºÑªe®c¤g¦a¤½¼q

³s«°¸ô249¸¹

1400-1600

 

¤T. ·s«a¬Ì­]±µºØ¨Æ¶µ»¡©ú

¤½¶O±µºØ¹ï¶H¬°65·³¥H¤WªøªÌ(48(§t)¥H«e¥X¥Í)¡A¨Ì¤£¦P±µºØ±¡§Î¡A¤À¶¥¬q¶}¥´

(¤@)        ¤½¶O¬Ì­]¡G

 

Ãþ§O

¶¥¬q

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

¤¤¥¡¤½¶O

²Ä¤@¶¥¬q

(2025.10.01°_)

¦P¬y·P¬I¥´²Ä¤@¶¥¬q¹ê¬I¹ï¶H

1.     °·«O¥d

2.     ¨­¤ÀÃÒ

150¤¸

²Ä¤G¶¥¬q

(2025.11.01°_)

¥X¥Íº¡6­Ó¤ë¥H¤WªÌ(¥¼¦C¦b²Ä¤@¶¥¬q¹ê¬I¹ï¶H)

1.     °·«O¥d

2.     ¨­¤ÀÃÒ

150¤¸

 

(¤G)        ¦Û¶O¬Ì­]¡G

Ãþ§O

¹ê¬I¹ï¶H

Àˮ֤å¥ó

¦¬¶O

¦Û¶O

±ý¦Û¶O±µºØ¤§¥Á²³

1.     °·«O¥d

2.     ¨­¤ÀÃÒ

¨Ìªù¶E¹ê»Ú¦¬¶O

 


 

u  ²ö¼w¯Ç¡]Spikevax¡^JN.1 COVID-19 ¬Ì­]¬ÛÃö¸ê°T

https://shh.tmu.edu.tw/upload_files/covidvacc/index.html

 

¤­.°Ñ¦Ò¸ê®Æ

(¤@)          °ª­·ÀIºC©Ê¯f¯e¯f¥N½X¤@Äýªí

ICD-10

¤jÃþ

¤ÀÃþ¦WºÙ

¤¤¤å¯f¦W

ICD-10-CM
½s½X

­^¤å¯f¦W (ICD-10-CM)

B

·P¬V¯g

¤HÃþ§K¬Ì¤£¥þ¯f¬r¯e¯f©Î·P¬V

B20,Z21

B20: Human immunodeficiency virus [HIV] disease
Z21: Asymptomatic human immunodeficiency virus [HIV] infection status

D

¦å²G©M³y¦å¾¹©x¤Î¯A¤Î§K¬Ì¾÷Â઺¯e±w

§K¬Ì¯Ê¥F¯g

D80-84

D80: Immunodeficiency with predominantly antibody defects
D81: Combined immunodeficiencies
D82: Immunodeficiency associated with other major defects
D83: Common variable immunodeficiency
D84: Other immunodeficiencies

Ãþ¦×½F¯f»P¨ä¥L

D86,D89

D86: Sarcoidosis
D89: Other disorders involving the immune mechanism, not elsewhere classified

E

¤º¤À泌¡BÀç¾i©M¥NÁ¯e¯f

¿}§¿¯f

E08-13

E08: Diabetes mellitus due to underlying condition
E09: Drug or chemical induced diabetes mellitus
E10: Type 1 diabetes mellitus
E11: Type 2 diabetes mellitus
E13: Other specified diabetes mellitus

ªÎ­D¯g

E66

E66: Obesity

Ãþ¾ý¯»ÅÜ©Ê

E85

E85: Amyloidosis

G

¯«¸g¨t²Î»P·Pı¾¹©xªº¯e¯f

¤¤¼Ï¯«¸g¨t²Îµoª¢©Ê¯e¯fªº«á¿ò¯g

G09

G09: Sequelae of inflammatory diseases of central nervous system

©¬ª÷´Ë¤ó¯f

G20

G20: Parkinson's disease

ªü¯÷®üÀq¤ó¯f»P¨ä¥L¯«¸g°h¤Æ©Ê¯e¯f

G30-32

G30: Alzheimer's disease
G31: Other degenerative diseases of nervous system, not elsewhere classified
G32: Other degenerative disorders of nervous system in diseases classified elsewhere

¦hµo©Êµw¤Æ¯g»P¨ä¥L²æÅèÀT¯e¯f

G35-37

G35: Multiple sclerosis
G36: Other acute disseminated demyelination
G37: Other demyelinating diseases of central nervous system

Åöíw¤Î­«Âеo§@

G40

G40: Epilepsy and recurrent seizures

µu¼È©Ê¸£¯Ê¦åµo§@»P¸£¦åºÞ¯e¯f©Ò­Pªº¸£¦åºÞ¯g­Ô¸s

G45-46

G45: Transient cerebral ischemic attacks and related syndromes
G46: Vascular syndromes of brain in cerebrovascular diseases 

µoª¢©Ê¤Î¬r©Ê¦hµo神¸g¯fÅÜ«á¿ò¯g

G65

G65: Sequelae of inflammatory and toxic polyneuropathies

­«¯g¦ÙµL力

G70

G70: Myasthenia gravis and other myoneural disorders

¨ä¥L¤Î¥¼¯S©w¤§¦Ù¯fÅÜ

G72

G72: Other and unspecified myopathies

I

´`Àô¨t²Î
¯e¯f

­·Àã¼ö»PºC©Ê­·Àã©Ê¤ßŦ¯f

I00-02,

I05-09

I00: Rheumatic fever without heart involvement                                 
I01: Rheumatic fever with heart involvement                                I02: Rheumatic chorea
I05: Rheumatic mitral valve diseases        
I06: Rheumatic aortic valve diseases          
I07: Rheumatic tricuspid valve diseases  
I08: Multiple valve diseases                        
I09: Other rheumatic heart diseases

°ª¦åÀ£¯e¯f

I11-13

I11: Hypertensive heart disease
I12: Hypertensive chronic kidney disease
I13: Hypertensive heart and chronic kidney disease

¤ßµ±µh»P¨ä¥L¯Ê¦å©Ê¤ßŦ¯f

I20-22,

I24-25

I20: Angina pectoris
I21: ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
I22: Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
I24: Other acute ischemic heart diseases
I25: Chronic ischemic heart disease

ªÍ©Ê¤ßŦ¯f

I27-28

I27: Other pulmonary heart diseases
I28: Other diseases of pulmonary vessels

佤¯e¯f

I34-37

I34: Nonrheumatic mitral valve disorders


I35: Nonrheumatic aortic valve disorders


I36: Nonrheumatic tricuspid valve disorders


I37: Nonrheumatic pulmonary valve disorders

¤ß¦Ù¯fÅÜ

I42-43

I42: Cardiomyopathy
I43: Cardiomyopathy in diseases classified elsewhere

¤ßŦ¶Ç¾É
¯e¯f

I44-45,

I47-49

I44: Atrioventricular and left bundle-branch block
I45: Other conduction disorders
I47: Paroxysmal tachycardia
I48: Atrial fibrillation and flutter
I49: Other cardiac arrhythmias

¤ß°IºÜ»P
¨ä¥L

I50-51

I50: Heart failure
I51: Complications and ill-defined descriptions of heart disease

«D¥~¶Ë©Ê¸£¥X¦å

I60-62

I60: Nontraumatic subarachnoid hemorrhage
I61: Nontraumatic intracerebral hemorrhage
I62: Other and unspecified nontraumatic intracranial hemorrhage

¸£±ð¶ë

I63

I63: Cerebral infarction

¨ä¥L¸£¦åºÞ¯e¯f©Î¨ä«á¿ò¯g

I67-69

I67: Other cerebrovascular diseases
I68: Cerebrovascular disorders in diseases classified elsewhere
I69: Sequelae of cerebrovascular disease

°Ê¯ßµ°¼Ëµw¤Æ

I70

Atherosclerosis

°Ê¯ß½F

I71,72

I71: Aortic aneurysm and dissection
I72: Other aneurysm

¨ä¥L¦åºÞ
¯e¯f

I73-74,

I77, I79

I73: Other peripheral vascular diseases


I74: Arterial embolism and thrombosis


I77: Other disorders of arteries and arterioles


I79: Disorders of arteries, arterioles and capillaries in diseases classified elsewhere

J

©I§l¨t²Î
¯e¯f

¤ä®ðºÞª¢»P¨ä¥LºC©Êªý¶ë©ÊªÍ¯e¯f

J40-45

J40: Bronchitis, not specified as acute or chroni
J41: Simple and mucopurulent chronic bronchitis

J42: Unspecified chronic bronchitis
J43: Emphysema

J44: Other chronic obstructive pulmonary disease
J45: Asthma

¤ä®ðºÞ
ÂX±i¯g

J47

J47: Bronchiectasis

ªÍ¨IµÛ¯g¤Î¥~¦]©Ò­P¤§ªÍ¯e¯f

J60-70

J60: Coalworker's pneumoconiosis

J61: Pneumoconiosis due to asbestos and other mineral fibers 
J62: Pneumoconiosis due to dust containing silica
J63: Pneumoconiosis due to other inorganic dusts  

J64: Unspecified pneumoconiosis
J65: Pneumoconiosis associated with tuberculosis

J66: Airway disease due to specific organic dust
J67: Hypersensitivity pneumonitis due to organic dust

J68: Respiratory conditions due to inhalation of chemicals, gases, fumes and vapors

J69: Pneumonitis due to solids and liquids
J70: Respiratory conditions due to other external agents

¨ä¥LªÍ³¡
¯e¯f

J82,J84,J96,

J98,J99

J82: Pulmonary eosinophilia, not elsewhere classified


J84: Other interstitial pulmonary diseases


J96: Respiratory failure, not elsewhere classified


J98: Other respiratory disorders

J99: Respiratory disorders in diseases classified elsewhere

K

®ø¤Æ¨t²Î
¯e¯f

ºC©Ê¨xª¢»P¨xµw¤Æ

K70-72,

K73-76,

B18-19

K70: Alcoholic liver disease
K71: Toxic liver disease
K72: Hepatic failure
¡Anot elsewhere classified
K73: Chronic hepatitis, unspecified

K74: Fibrosis
K75: Other inflammatory disease of liver K76: other diseases of liver
B18: Chronic viral hepatitis
B19: Unspecified viral hepatitis

M

¦Ù¦×°©Àf¨t²Î¤Îµ²½l²Õ´¯e¯f

Ãþ­·Àã©ÊÃö¸`ª¢

M05-06

M05: Rheumatoid arthritis with rheumatoid factor
M06: Other rheumatoid arthritis

¥þ¨­©Ê¦ÛÅé§K¬Ì¯g­Ô¸s

M30-31, M32-34

M30: Polyarteritis nodosa and related conditions
M31: Other necrotizing vasculopathies
M32: Systemic lupus erythematosus (SLE)
M33: Dermatopolymyositis
M34: Systemic sclerosis [scleroderma]

¨ä¥Lµ²½l²Õ´¯e¯f

M35, M94.1

M35: Other systemic involvement of connective tissue
M94.1: Relapsing polychondritis

N

¥Í´Þªc§¿¨t²Î¯e¯f

µÇª¢¯g­Ô¸s

N00-01,N03,

N05

N00: Acute nephritic syndrome
N01: Rapidly progressive nephritic syndrome
N03: Chronic nephritic syndrome
N05: Unspecified nephritic syndrome

µÇ¯f¯g­Ô¸s

N04

N04: Nephrotic syndrome

ºC©ÊµÇ°IºÜ¤ÎµÇ°IºÜ¥¼©ú¥ÜªÌ

N18-19

N18: Chronic kidney disease (CKD)
N19: Unspecified kidney failure

µÇŦµäÁY

N26-27

N26: Unspecified contracted kidney

N27: Small kidney of unknown cause

Q

¥ý¤Ñ©Ê·î§Î¡BÅܧλP¬V¦âÅé²§±`

¥ý¤Ñ©Î«á¤ÑµÊŦ¯Ê·l

Q89.01,

Z90.81

Q89.01: Asplenia (congenital)
Z90.81: Post-surgical absence of spleen

 


 

(¤G)  ¨u¨£¯e¯f¤ÀÃþ§Ç¸¹·JÁ`ªí(111.07.13)

¤ÀÃþ

§Ç¸¹

¤¤¤å¯f¦W

¡]¶È¨Ñ°Ñ¦Ò¡^

­^¤å¯f¦W(ÁY¼g)

ICD-10-CM¶EÂ_¥N½X

A.¥ý¤Ñ©Ê¥NÁ²§±`

¡·A1§¿¯À´`Àô¥NÁ²§±` Urea cycle disorders ¡]°ª¦å®ò¯g¡^

A1

01

¥ý¤Ñ©Ê§¿¯À´`Àô¥NÁ»Ùê

Congenital  Urea cycle disorders

E72.20

 

02

¥ÊÓi»Ä¦å¯g

Citrullinemia

E72.23

 

03

¤AñQâBÓi»Ä¦X¦¨–¡¯Ê¥F¯g

 

Nitroacetylglutamate synthetase deficiency, NAG synthetase deficiency

E72.29

 

04

³¾Ói»Ä®ò¥ÒñQ°òÂಾ–¡¯Ê¥F¯g

Ornithine transcarbamylase deficiency

E72.4

 

05

°ª³¾Ói»Ä¦å¯g-°ª®ò¦å¯g-°ª¥ÊÓi»Ä¦å¯g¯g­Ô¸s

Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome

E72.4

¡· A2 Ói°ò»Ä/¦³¾÷»Ä¥NÁ²§±` Amino acid metabolic disorders / Organic acidemias

A2

01

Ói°ò»Ä¥NÁ¯e¯f

Amino acid metabolic disorders¡]Aminoacidopathies¡^

E72.8

 

02

°ª¯ÖÓi»Ä¦å¯g

Homocystinuria

E72.11

 

03

°ª¥Ò²¸Ói»Ä¦å¯g

Hypermethioninemia

E72.19

 

04

«D଩ʰª¥ÌÓi»Ä¦å¯g

Nonketotic hyperglycinemia

E72.51

 

05

­fଧ¿¯g

Phenylketouria

E70.0

 

06

¥|²B°ò³ãËï¯Ê¥F¯g

Tetrahydrobiopterin deficiency

E70.1

 

07

¿ò¶Ç©Ê°ª¹TÓi»Ä¦å¯g

Hereditary tyrosinemia

E70.21

 

08

·¬¿}§¿¯g

Maple syrup urine disease

E71.0

 

09

¦³¾÷»Ä¦å¯g

Organic acidemias

E71.118

 

10

²§¥³»Ä¦å¯g

Isovaleric acidemia

E71.110

 

11

¥³¤G»Ä§¿¯g¡A²Ä¤@«¬¡B²Ä¤G«¬

Glutaric aciduria type ¢¹¡B¢º

type I:E72.3

type11:E71.313

 

12

¤þ»Ä¦å¯g

Propionic acidemia

E71.121

 

13

¥Ò°ò¤þ¤G»Ä¦å¯g

Methylmalonic acidemia

E71.120

 

14

3-ßm°ò-3-¥Ò°ò¥³¤G»Ä¦å¯g

3-Hydroxy-3-methyl-methylglutaric acidemia

E71.118

 

15

¨å«¬­fଧ¿¯g¦X¨Ö½©¿}–¡¦P³ÁªÞ¿}–¡¯Ê¥F¯g

PAH type PKU combine with Sucrase-isomaltase deficiency

E74.31+E70.0

 

16

°ªÂ÷Ói°ò»Ä¦å¯g

Hyperlysinemia

E72.3

 

17

²ÕÓi»Ä¦å¯g

Histidinemia

E70.41

 

18

¤T¥Ò°ò¤Ú¨§ñQ»²–¡Aßn¤Æ»Ã¯À¯Ê¥F¯g

3-Methylcrotonyl-CoA carboxylase deficiency

E71.19

 

19

¦hµo©Êßn¤Æ–¡¯Ê¥F¯g

Multiple carboxylase deficiency

D81.819

 

20

°ª²ãÓi»Ä¦å¯g

Hyperprolinemia

E72.59

 

21

ªÚ­»±ÚL-Ói°ò»ÄÃþ²æßn°ò–¡¯Ê¥F¯g

Aromatic L-amino acid decarboxylase deficiency

E70.9

 

22

¹TÓi»Äßm¤Æ–¡¯Ê¥F¯g

Tyrosine hydroxylase deficiency

E70.20

 

23

¥Ò°ò¤þ¤G»Ä¦å¯g¨Ö°ª¯ÖÓi»Ä¦å¯g¡]Cbl C«¬¡^

Cobalamin C defect ¡]Methylmalonic aciduria and Homocystinuria, cbl C type¡^

E71.120+E72.11

¡· A3¯×½èÀx¿n

A3

01

°ª³·¤ó¯g

Gaucher¡¦s disease

E75.22

 

02

GM1/GM2¯«¸g¸`–£¯×Àx¿n¯g

GM1/GM2 gangliosidosis

GM1:E75.19

GM2: E75.00

 

03

Fabry ¤ó¯g

Fabry disease

E75.21

 

04

Niemann-Pick¤ó¯g¡AÀTÅèÁC¯×Àx¿n¯g

Niemann-Pick disease

E75.240:Type A

E75.241:Type B

E75.242:Type C

E75.243:Type D

E75.248:other

E75.249:unspecified

 

05

MLD¯g­Ô¸s

Metachromatic Leukodystrophy¡]MLD¡^

E75.25

 

06

²y²Ó­M¸£¥Õ½è¥¢¾i¯g

Globoid Cell Leukodystrophy (Krabbe¡¦s  disease)

E75.23

 

07

À¦¨à«¬·»–¡Åé»Ä©Ê¯×ªÕ–¡¯Ê¥F¯g¡]¤SºÙ¥îº¸°Ò¤ó¯g¡^

Infantile form Lysosomal Acid Lipase Deficiency ¡]Wolman Disease¡^

E75.5

¡·A4ºÒ¤ô¤Æ¦Xª«¥NÁ²§±`

A4

01

¥b¨Å¿}¦å¯g

Galactosemia

E74.21

 

02

¨xÁÞÀx¿n¯g

Glycogen storage disease

E74.09:type 0

E74.01:Type I

E74.02:type II

E74.03:type III

E74.09:type IV

E74.04:type V

E74.09:type VI-XI

E74.01:Von Gierke's

 

03

¸£¦åºÞ«Ì»Ù¸²µå¿}¿é°e¯Ê³´

Glut¡]Glucose Transport¡^1 deficiency syndrome

E74.8

 

04

ÂàîǾJ–¡¯Ê¥F¯g

Transaldolase deficiency

E74.8

¡· A5¯×ªÕ»Ä®ñ¤Æ²§±`

 

01

¯×ªÕ»Ä®ñ¤Æ§@¥Î¯Ê³´

Fatty acid oxidation defect

E71.30

E71.310

E71.311

E71.312

E71.313

E71.314

E71.318

E71.32

E71.39

 

02

­ìµo©Ê¦×ÆP¯Ê¥F¯g

Carnitine deficiency syndrome, primary

E71.41

 

03

¤¤Ãì¯×ªÕ»Ä¥h²B»Ã¯À¯Ê¥F¯g

Medium-chain acyl-coenzyme A dehydrogenase deficiency¡]MCAD¡^

E71.311

 

04

µuÃì¯×ªÕ»Ä¥h²B–¡¯Ê¥F¯g

Short-chain acyl-CoA dehydrogenase deficiency

E71.312

¡· A6²É½uÅé¥NÁ²§±`

A6

01

²É½uÅé¯Ê³´

Mitochondrial defect

E88.40

 

02

Kearns-Sayre ¤ó¯g­Ô¸s

Kearns-Sayre syndrome

H49.811

H49.812

H49.813

H49.819

 

03

Leigh ¤óµ£¦~´Á¸£¯áÅè¯fÅÜ

Leigh disease

G31.82

 

04

MELAS¯g­Ô¸s

MELAS

E88.41

 

05

MNGIE¯g­Ô¸s²É½uÅé©Ê¯«¸g­G¸z¸£¯fÅܯg­Ô¸s

Mitochondrial Neurogastrointestinal Encephalopathy Syndrome

E88.49

 

 

06

¤þà¬»ÄÆQ²æ²B–¡¯Ê¥F¯g

Pyruvate dehydrogenase deficiency

E74.4

 

07

¤Ú¤ó¯g­Ô¸s

Barth Syndrome

E78.71

 

08

¹p§B¤ó¿ò¶Ç©Êµø¯«¸g¯fÅÜ

Leber hereditary optic neuropathy

H47.22

¡· A7·»¤pÅé¥NÁ²§±`

A7

01

¯ÖÓi»Ä¦å¯g

Cystinosis

E72.04

 

02

ÂH¦hÁÞ¯g

Mucopolysaccharidoses

Type1: E76.01

E76.02

E76.03

Type2:E76.1

other¡G

E76.210

E76.211

E76.219

E76.22

E76.29

Unspecified:E76.3

 

03

©¥Ä¦¿}¥NÁ²§±`¡]Àx¿n¯g¡^

Fucosidosis

E77.1

 

04

²C»Ä»Ã¯À¯Ê¥F¯g

Sialidosis

E77.1

 

05

ÂH¯×½è¯g

Mucolipidosis

type I:E77.1

type II¡BIII: E77.0

type IV:E75.11

 

06

¯«¸g¤¸Äú¼Ë¯×½Å½èÀx¿n¯g

Neuronal ceroid lipofuscinosis

E75.4

 

07

¦hµo©Ê²¸»Ä¯×–¡¯Ê¥F¯g

Multiple Sulfatase deficiency

E75.29

¡· A8Áx©T¾J¤Î¯×½è¥NÁ²§±`Cholesterol and Lipid metabolism

A8

01

¦P¦X¤l®a±Ú©Ê°ªÁx©T¾J¦å¯g

Homozygous familial hypercholesterolemia

E78.0

 

02

®a±Ú©Ê°ª¨ÅÁS·L²É¦å¯g

Familial Hyperchylomicronemia

E78.3

 

03

¨§©T¾J¦å¯g¡]´Óª«©Ê¡^

Sitosterolemia

E78.0

¡·A9Äqª«Â÷¤l¯Ê³´

A9

01

«Âº¸´Ë¤ó¯g

Wilson¡¦s  disease

E83.01

 

02

Menkes ¯g­Ô¸s

Menkes syndrome

E83.09

 

03

à»»²–¡¯Ê¥F¯g

Molybdenum cofactor deficiency

E61.5

¡· A10¹L®ñ¤ÆÅé¥NÁ²§±`

A10

01

Zellweger¤ó¯g­Ô¸s

Zellweger syndrome

E71.510

 

02

µÇ¤W¸¢¸£¥Õ½è¥¢¾i¯g

Adrenoleukodystrophy

E71.511

E71.520

E71.521

E71.528

E71.529

 

03

ªÏªñºÝ«¬ÂIª¬³n°©µo¨|¤£¨}

Rhizomelic Chondrodysplasia Punctata

E71.540

¡· A11¨ä¥L¥NÁ²§±`

 

01

µµ½è¯g

Porphyria

E80.20

E80.21

E80.29

 

02

Lesch-Nyhan¤ó¯g­Ô¸s

Lesch-Nyhan syndrome

E79.1

 

03

¨È²¸»ÄÆQ®ñ¤Æ–¡¯Ê¥F

Sulfite oxidase deficiency

E72.19

 

04

ºÒ¤ô¤Æ¦X¯Ê¥FÁÞ³J¥Õ¯g­Ô¸s

Carbohydrate-deficiency glycoprotein syndrome

E77.8

 

05

¤T¥Ò°òÓi§¿¯g

Trimethylaminuria

E72.52

 

06

¥ý¤Ñ©Ê¥þ¨­¯×½èÀç¾i¤£¨}¯g

Congenital generalized lipodystrophy

E88.1

 

07

¸£¸x©Ê¶À½F¯g

Cerebrotendinous Xanthomatosis

E75.5

 

08

§CÁC»Äà­–¡¯g

Hypophosphatasia

E83.39

E83.31

 

09

Beta²¸¸Ñ–¡¯Ê¥F¯g

Beta-Ketothiolase Deficiency

E71.19

 

10

¥Íª«¯À–¡¯Ê¥F¯g

Biotinidase Deficiency

D81.810

 

11

¤j¸£¦Ù»Ä¯Ê¥F¯g

Cerebral Creatine Deficiency

E72.8

 

12

²¸Ói¯À¡]ºû¥Í¯ÀB1¡^¥NÁÂ¥\¯à»Ùê¯g­Ô¸s

Thiamine Metabolism Dysfunction Syndromes

E51.8

B ¸£³¡©Î¯«¸g¨t²Î¯fÅÜ

B1

01

¦hµo©Êµw¤Æ¯g/ªxµø¯«¸g¯áÅ誢

Multiple Sclerosis,MS/ Neuromyelitis Optica Spectrum Disorders, NMOSD

G35/G36.0

 

02

¦ÙµäÁY©Ê°¼¯Áµw¤Æ¯g

Amyotrophic lateral sclerosis¡]ALS¡^

G12.21

 

03

¦@ÀÙ¥¢½Õ·L¦åºÞÂX±i¯g­Ô¸s

Ataxia telangiectasia

G11.3

 

04

¦ë¤B¹y¤ó»RÁЯg

Huntington disease¡]¤SºÙHuntington's chorea¡^

G10

 

05

¹p¯S¤ó¯g

Rett syndrome

F84.2

 

06

¯áÅè©Ê¦Ù¦×µäÁY¯g

Spinal muscular atrophy

G12.9

 

07

¯áÅè¤p¸£°h¤Æ©Ê°Ê§@¨ó½Õ»Ùê

Spinocerebellar ataxia

G11.1

 

08

µ²¸`©Êµw¤Æ¯g

Tuberous sclerosis

Q85.1

 

09

¥ý¤Ñ©Êµh¤£±Ó·P¯g¦X¨ÖµL¦½¯g

Congenital insensitivity to pain with anhidrosis¡]CIPA¡^

L74.4

 

10

¯«¸gÅÖºû½F¯g­Ô¸s²Ä¤G«¬

Neurofibromatosis type ¢º

Q85.02

 

11

Alexander ¤ó¯f

Alexander disease

E75.29

 

12

»øÅé¯g­Ô¸s

Stiffperson syndrome

G25.82

 

13

¿ò¶Ç©ÊµjÅ˩ʤU¨­³Â·ô

Hereditary spastic paraplegia

G11.4

 

14

Joubert¤ó¯g­Ô¸s¡]®a±Ú©Ê¤p¸£°C³¡µo¨|¤£¥þ¡^

Joubert syndrome

Q04.3

 

15

Pelizaeus-Merzbacher¤ó¯g¡]ºC©Ê¨àµ£«¬¸£µw¤Æ¯g¡^

Pelizaeus-Merzbacher Disease

E75.29

 

16

®L¬_-°¨§Q-§ù´µ¤ó¯g

Charcot-Marie-Tooth Disease

G60.0

 

17

¥Ì°i­}¤ó¯g(¯áÅ詵Åè©Ê¦Ù¦×µäÁY¯g)

Kennedy  Disease

G12.20

G12.21

G12.22

G12.29

 

18

®a±Ú©Ê¾ý¯»¼Ë¦hµo©Ê¯«¸g¯fÅÜ

Familial Amyloidotic Polyneuropathy

E85.1

 

19

Moebius¯g­Ô¸s

Moebius syndrome

Q87.0

 

20

Mcleod ¯g­Ô¸s

Mcleod syndrome

Q97.8

Q98.8

 

21

Aicardi-Goutieres¯g­Ô¸s

Aicardi-Goutieres syndrome

G31.89

 

22

´¶¬¥´£´µ¯g­Ô¸s

Proteus Syndrome

Q87.3

 

23

MECP2 ºî¦X¯g­Ô¸s

Methyl CpG binding protein 2 Duplication Syndrome

¡]MECP2 Duplication Syndrome¡^

Q99.8

 

24

¸£¦Ø¤p¾g¯g­Ô¸s

Cerebro-Costo-Mandibular Syndrome

Q87.89

 

25

Dravet¯g­Ô¸s

Dravet Syndrome, DS

G40.311

 

26

¸£¥Õ½è®ø¥¢¯g

Vanishing White Matter Disease

G37.8

 

27

ªx»ÄÆQ¿E–¡ÃöÁp¤§¯«¸g°h¤Æ©Ê¯e¯f

Pantothenate Kinase Associated Neurodegeneration¡]PKAN¡^

G23.0

 

28

ÁC¯×½è¯×¸Ñ–¡A2ÃöÁp¤§¯«¸g°h¤Æ©Ê¯e¯f

Phospholipase A2-associated neurodegeneration ¡]PLAN¡^

G23.0

 

29

¥Ö¯S-ÀN´¶ª÷´µ¯g­Ô¸s

Pitt-Hopkins Syndrome

Q87.0

 

30

Beta Á³±Ûª¬³J¥ÕÃö

Áp¤§¯«¸g°h¤Æ¯e¯f

Beta-Propeller Protein-

Associated Neurodegeneration

¡]BPAN¡^

G23.0

 

31

À¦¨à«¬¤W¦æ©Ê¿ò¶Ç©ÊµjÅ˩ʳ·ô

Infantile-Onset Ascending

Hereditary Spastic

Paralysis,¡@IAHSP

G12.2

C    ©I§l´`Àô¨t²Î¯fÅÜ

C1

01

¯Sµo©ÊÀ¦¨à°Ê¯ßµw¤Æ¯g

Idiopathic Infantile Arterial Calcification

Q28.8

 

02

Ånª¬ÅÖºû¤Æ¯g

Cystic fibrosis

E84.9

 

03

¯Sµo©Ê©Î¿ò¶Ç©ÊªÍ°Ê¯ß°ªÀ£

Idiopathic or Heritable pulmonary arterial hypertension¡]IPAH or HPAH¡^

I27.0

 

04

Holt-Oram¤ó¯g­Ô¸s

Holt-Oram Syndrome

Q87.2

 

05

Andersen¤ó¯g­Ô¸s¡]¤ß¸`«ß»Ùêº[¶g´Á©Ê³Â·ô¯g­Ô¸s¡F¹[Â÷¤l³q¹D¯fÅÜ¡^

Andersen syndrome

E74.09

 

06

¿ò¶Ç©Ê¥X¦å©Ê¦åºÞÂX±i¯g

Hereditary Hemorrhagic Telangiectasia

I78.0

 

07

²¿®§©Ê¯ÝµÄ¥¢¾i¯g

Asphyxiating thoracic dystrophy

Q77.2

 

08

¥ý¤Ñ©Ê¤¤¼Ï©Ê´«®ð¤£¨¬¯g­Ô¸s

Congenital Central Hypoventilation Syndrome

G47.35

D   ®ø¤Æ¨t²Î¯fÅÜ

 

01

¶i¦æ©Ê®a±Ú©Ê¨x¤ºÁx¥Äº¢¯d¯g

Progressive familial cholestasis, PFIC

K83.1

 

02

¥ý¤Ñ©ÊÁx»Ä¦X¦¨»Ùê

Inborn errors of bile acid synthesis

E78.70

 

03

£\1-§Ü¯Ø³J¥Õ–¡¯Ê¥F¯g

£\1- Antitrypsin  deficiency

E88.01

 

04

¥ý¤Ñ©ÊCajal¤ó¶¡½è²Ó­M¼W¥Í¦X¨Ö¸z¹D¯«¸g¤¸µo¨|²§±`

Congenital Interstitial Cell of Cajal Hyperplasia with Neuronal Intestinal Dysplasia

Q43.8

 

05

ªü©Ô¦N¼Ú¯g­Ô¸s

Alagille Syndrome

Q44.7

E    µÇŦªc§¿¨t²Î¯fÅÜ

E1

01

Lowe ¤ó¯g­Ô¸s

Lowe syndrome

E72.03

 

02

Bartter¤ó¯g­Ô¸s

Bartter¡¦s syndrome

E26.81

 

03

Åé¬V¦âÅéÁô©Ê¦hÅn©ÊµÇŦ¯e¯f

Autosomal recessive polycystic kidney disease

Q61.19

 

04

¨È§B¤ó¯g­Ô¸s

Alport Syndrome

Q87.81

F   ¥Ö½§¯fÅÜ

F1

01

¿ò¶Ç©Êªí¥Ö¤À¸Ñ©Ê¤ô¯p¯g

Hereditary epidermolysis bullosa

Q81.0

Q81.1

Q81.2

Q81.8

Q81.9

 

02

¼hª¬³½ÅìÅ~¡]¦ÛÅéÁô©Ê¿ò¶Ç«¬)

Ichthyosis, lamellar recessive

Q80.2

 

03

½¦½¤¨à

Collodion baby

Q80.2

 

04

´³¦â³½ÅìÅ~

Harlequin ichthyosis

Q80.4

 

05

¤ôªw«¬¥ý¤Ñ©Ê³½ÅìÅ~¼Ë¬õ¥Ö¯g¡]ªí¥ÖÃP¸Ñ©Ê¨¤¤Æ¹L«×¯g¡^

Bullous Congenital ichthyosiform erythoderma

¡]epidermolytic hyperkeratosis¡^

Q80.3

 

06

¥~­F¼h¼W¥Í¤£¨}¯g

Ectodermal Dysplasias

Q82.4

 

07

Meleda®q¯f

Meleda disease

Q82.8

 

08

Darier¤ó¯g¡]¤òÅn¨¤¤Æ¯f¡^

Darier¡¦s disease

Q82.8

 

09

¥ý¤Ñ©Ê¨¤¤Æ¤£¥þ¯g

Dyskeratosis  Congenita

Q82.8

 

10

¥Ö½§¹L«×¨¤¤Æ¯g¶®¥q¯f

Diffuse Non-epidermolytic Palmoplantar Keratoderma type Unna-Thost

Q82.8

 

11

¦â¯À¥¢½Õ¯g

Incontinentia Pigmenti

Q82.3

 

12

Netherton¯g­Ô¸s

Netherton Syndrome

Q80.3

G  ¦Ù¦×¯fÅÜ

G1

01

¸ÊÄɤó¦Ù¦×¥¢¾i¯g

Duchenne muscular dystrophy

G71.0

 

02

Nemaline½uª¬¦Ù¦×¯fÅÜ

Nemaline Rod Myopathy

G71.2

 

03

Schwartz Jampel¤ó¯g­Ô¸s

Schwartz Jampel syndrome

G71.13

 

04

¦Ù¦×±jª½¯g

Myotonic dystrophy

G71.11

 

05

­±ªÓ­KªÐ¦Ù¥¢¾i¯g

Facioscapulohumeral muscular dystrophy

G71.0

 

06

¦Ù¤pºÞ¯fÅÜ

Myotubular Myopathy

G71.2

 

07

¨©§J«¬¦Ù¦×¥¢¾i¯g

Becker Muscular Dystrophy

G71.0

 

08

Freeman-Sheldon¤ó¯g­Ô¸s

Freeman-Sheldon syndrome

Q87.0

 

09

ªÏ±a«¬¦Ù¥¢¾i¯g

Limb-girdle muscular dystrophy

G71.0

 

10

¥ý¤Ñ©Ê¦Ù¥¢¾i¯g

Congenital Muscular Dystrophy

G71.0

 

11

¤¤¤ß¶bªÅ¦Ù¯f

Central Core Disease

G71.2

 

12

¦h·L¤p¶bªÅ¦Ù¯f

Multiminicore Disease

G71.2

 

13

Emery¡VDreifuss¦Ù¥¢¾i¯g

Emery¡VDreifuss

¢Ûuscular Dystrophy¡]EDMD¡^

G71.0

 

14

GNE»·ºÝ¦Ù¯fÅÜ

GNE myopathy

G71.8

 

15

¥v¦«¼¯®Ú¯g­Ô¸s

Stormorken syndrome

D69.8

H   °©¤Î³n°©¯fÅÜ

H1

01

³n°©µo¨|¤£¥þ¯g

Achondroplasia

Q77.4

 

02

¦¨°©¤£¥þ¯g

Osteogenesis imperfecta

Q78.0

 

03

­ìµo©ÊÅܧΩʰ©ª¢

Primary Paget disease

M88.0

M88.1

M88.811

M88.812

M88.819

M88.821

M88.822

M88.829

M88.831

M88.832

M88.839

M88.841

M88.842

M88.849 

M88.851

M88.852

M88.859

M88.861

M88.862

M88.869

M88.871

M88.872

M88.879

M88.88

M88.89

M88.9

 

04

Âê°©Æ`°©µo¨|²§±`

Cleidocraninal dysplasia

Q74.0

 

05

¶i¦æ©Ê°©¤Æ©Ê¦Ùª¢

Fibrodysplasia Ossificans Progressiva

M61.10

M61.111

M61.112

M61.119

M61.121

M61.122

M61.129

M61.131

M61.132

M61.139

M61.141

M61.142

M61.143

M61.144

M61.145

M61.146

M61.151

M61.152

M61.159

M61.161

M61.162

M61.169

M61.171

M61.172

M61.173

M61.174

M61.175

M61.176

M61.177

M61.178

M61.179

M61.18

M61.19

 

06

µõ¤âµõ¨¬¯g

Split-hand/ Split-foot malformation¡]SHFM¡^

Q71.60

Q71.61

Q71.62

Q71.63

Q72.70

Q72.71

Q72.72

Q72.73

 

07

°©½è¥Û¤Æ¯g

Osteopetrosis

Q78.2

 

08

°²©Ê³n°©µo¨|¤£¥þ

Pseudoachondroplastic dysplasia

Q77.8

 

09

¦hµo©Ê°©ýæµo¨|¤£¥þ¯g

Multiple Epiphyseal Dysplasia

Q78.3

 

10

Æ`°©·FýæºÝµo¨|¤£¨}

Craniometaphyseal Dysplasia

Q78.8

I   µ²½l²Õ´¯fÅÜ

I1

01

¥ý¤Ñµ²½l²Õ´²§±`²Ä¥|«¬

Ehlers Danlos syndrome ¢¼

Q79.6

J    ¦å²G¯e¯f

 

01

­««¬®ü¬v©Ê³h¦å

Thalassemia major

D56.0

D56.1

 

02

¦å¤pªOµL¤O¯g

Thrombasthenia

D69.1

 

03

¦P°ò¦]¦X¤l³J¥Õ½èC¯Ê¥F¯g

Homozygous protein C  deficiency

D68.59

 

04

°}µo©Ê©]¶¡¦å¬õ¯À§¿¯g

Paroxysmal Nocturnal Hemoglobinuria

D59.5

 

05

«D¨å«¬©Ê§¿¬r·»¦å¯g­Ô¸s

Atypical Hemolytic Uremic Syndrome

D59.3

K   §K¬Ì¯e¯f

K1

01

­ìµo©ÊºC©Ê¦×ªÞ¸~¯f

Chronic primary granulomatous disease

D71

 

02

¥ý¤Ñ©Ê°ª§K¬Ì²y³J¥ÕE¯g­Ô¸s

Congenital Hyper IgE syndrome

D82.4

 

03

¥¬¾|¹y¤ó§C§K¬Ì²y³J¥Õ¦å¯g

Bruton¡¦s agammaglobulinemia

D80.0

 

04

Wiskott- Aldrich¤ó¯g­Ô¸s

Wiskott- Aldrich Syndrome

D82.0

 

05

ÄY­«½Æ¦X«¬§K¬Ì¯Ê¥F¯g

Severe combined immunodeficiency

D81.0

D81.1

D81.2

D81.9

 

06

¸ÉÅ馨¥÷8¯Ê¥F¯g

Complement Component 8 deficiency

D84.1

 

07

IPEX ¯g­Ô¸s

IPEX Syndrome

E31.0

 

08

°ª§K¬Ì²y³J¥ÕM¯g­Ô¸s

Hyper-IgM syndrome

D80.5

 

09

£^ ¤zÂZ¯À¨üÅé1¯Ê³´

Interferon £^ receptor 1 deficiency

D84.8

 

10

¿ò¶Ç©Ê¦åºÞ©Ê¤ô¸~

Hereditary Angioedema¡]HAE¡^

D84.1

L   ¤º¤Àªc¯e¯f

L1

01

Kenny-Caffey¤ó¯g­Ô¸s

Kenny-Caffey syndrome

Q87.1

 

02

°²©Ê°Æ¥Òª¬¸¢§C¯à¯g

Pseudohypoparathyroidism

E20.1

 

03

©ÊÁp¿ò¶Ç«¬§CÁC»ÄÆQ§Fܼ¯g

X-linked hypophosphatemic rickets

E83.31

 

04

Laron ¤ó¨Ü¾§¯g­Ô¸s

Laron syndrome

¡]Laron Dwarfism¡^

E34.3

 

05

Bardet-Biedl¤ó¯g­Ô¸s

Bardet-Biedl syndrome

Q87.89

 

06

Alstrom¤ó¯g­Ô¸s

Alsrtom Syndrome

Q87.89

 

07

«ùÄò©Ê¥®¨à«¬¯Ø®q¯À¹L«×¤Àªc§C¦å¿}¯g

Persistent hyperinsulinemic hypoglycemia of infancy ¡]PHHI¡^

E16.1

 

08

Wolfram¤ó¯g­Ô¸s

Wolfram syndrome¡ADIDMOAD

E88.9

 

09

McCune Albright¤ó¯g­Ô¸s

McCune Albright syndrome

Q78.1

 

10

µu«üµo¨|¤£¨}¤Î©Ê§OÄA­Ë

Campomelic dysplasia with autosomal sex reversal

Q99.8

 

11

µÇ¤W¸¢¥Ö«P¯À§Ü©Ê

ACTH resistance

E27.49

 

12

²Ä¤@«¬¿ò¶Ç©Êºû¥Í¯ÀD¨Ì¿à«¬§Fܼ¯g

25-Hydroxyvitamin D 1-Alpha-Hydroxylase Deficiency

E83.32

 

13

¥ý¤Ñ©ÊµÇ¤W¸¢µo¨|¤£¥þ

Congenital adrenal hypoplasia

Q89.1

 

14

Kallmann¤ó¯g­Ô¸s

Kallmann syndrome

E23.0

 

15

¥Ã¤[©Ê·s¥Í¨à¿}§¿¯f

Permanent Neonatal Diabetes Mellitus

P70.2

 

16

MIRAGE¯g­Ô¸s

MIRAGE syndrome

Q89.8

M   ¥ý¤Ñ·î§Î¯g­Ô¸s

M1

01

Aarskog-Scott¤ó¯g­Ô¸s

Aarskog-Scott syndrome

Q87.1

 

02

¥Ëµn§B®æ¤ó¯g­Ô¸s

Waardenburg syndrome

E70.8

 

03

·R§B¯S¤ó¯g

Apert syndrome

Q87.0

 

04

Smith-Lemli-Opitz¤ó¯g­Ô¸s

Smith-Lemli-Opitz syndrome

E78.72

 

05

Larsen¤ó¯g­Ô¸s¡]ÃEµõ-¥ý¤Ñ©Ê²æ¦ì¯g­Ô¸s¡^

Larsen syndrome

Q74.8

 

06

Beckwith Wiedemann¤ó¯g­Ô¸s

Beckwith Wiedemann syndrome

Q87.3

 

07

Crouzon¤ó¯g­Ô¸s

Crouzon syndrome

Q75.1

 

08

Fraser¤ó¯g­Ô¸s

Fraser syndrome

Q87.0

 

09

¦hµo©ÊÁlª¬½¤¯g­Ô¸s

Multiple pterygium syndrome

Q79.8

 

10

Cornelia de Lange¤ó¯g­Ô¸s

Cornelia de Lange syndrome

Q87.1

 

11

®ü°Ç°Ò-¥v¼wµÜ¤Ò¤ó¯g­Ô¸s

Hallerman-Streiff Syndrome

Q87.0

 

12

Kabuki¯g­Ô¸s

Kabuki syndrome

Q89.8

 

13

¦Õ-øí-«ü¡]³k¡^¯g­Ô¸s

Oto-Palato-Digital syndrome

Q87.0

 

14

Conradi-Hunermann¤ó¯g­Ô¸s

Conradi-Hunermann syndrome

Q77.3

 

15

Treacher Collins¤ó¯g­Ô¸s

Treacher Collins Syndrome

Q75.4

 

16

Robinow¤ó¯g­Ô¸s

Robinow Syndrome

Q87.1

 

17

Pfeiffer¤ó¯g­Ô¸s

Pfeiffer syndrome

Q87.0

 

18

ªx»ÄÆQ¿E–¡ÃöÁp¤§¯«¸g°h¤Æ©Ê¯e¯f¡]²¾B27¡^

Pantothenate Kinase Associated Neurodegeneration¡]PKAN¡^

G23.0

 

19

«ü¡]³k¡^¥ÒøÔ°©¯g­Ô¸s

Nail-Patella Syndrome

Q87.2

 

20

CFC¯g­Ô¸s

Cardiofaciocutaneous Syndrome

Q87.89

 

21

Peters-Plus¯g­Ô¸s

Peters-Plus syndrome

Q13.4

 

22

Nager¯g­Ô¸s

Nager Syndrome

Q75.4

   

23

CHARGE¯g­Ô¸s

CHARGE Syndrome

Q89.8

 

24

Ãh¯S-ÂĹy¯g­Ô¸s

White-Sutton syndrome

Q99.8

F84.8

F78

 

25

§J´µ´£¬¥¤ó¼u©Ê³J¥Õ¯Ê³´¯g

Costello syndrome

Q87.89

 

26

Ayme-Gripp¯g­Ô¸s

Ayme-Gripp syndrome

Q87.89

 

27

 Coffin-Lowry¯g­Ô¸s

Coffin-Lowry Syndrome

Q89.8

 

28

Myhre¯g­Ô¸s

Myhre syndrome

Q87.89

 

29

´Ë´Ë¥¬­Û¯Ç¯g­Ô¸s

Sensenbrenner Syndrome

Q87.5

 

30

§J¤ù-¾|»«´µ°ò¯g­Ô¸s

Keppen-Lubinsky syndrome

E88.1

N   ¬V¦âÅé²§±`

N1

01

Angelman¤ó¯g­Ô¸s

Angelman syndrome

Q93.5

 

02

DiGeorge¯g­Ô¸s

DiGeorge¡¦s syndrome

D82.1

 

03

Prader-Willi¤ó¯g­Ô¸s

Prader-Willi syndrome

Q87.1

 

04

«Âº¸©i¤ó¸~½F¡BµL­i½¤¡B©Ê¾¹²§±`¡B´¼¯à»Ùê¯g­Ô¸s¡]W A G R¯g­Ô¸s¡^

WAGR syndrome¡]Wilms¡¦ tumor-Aniridia-Genitourinary Anomalies-mental Retardation¡^

Q87.89

 

05

Miller Dieker ¯g­Ô¸s

Miller Dieker syndrome

Q93.88

 

06

Rubinstein-Taybi¤ó¯g­Ô¸s

Rubinstein-Taybi syndrome

Q87.2

 

07

«Â·G´µ¤ó¯g­Ô¸s

Williams Syndrome

Q93.89

 

08

Von Hippel¡VLindau ¯g­Ô¸s

Von Hippel¡VLindau disease

Q85.8

 

09

Branchio-Oto-Renal Syndrome¡]BOR Syndrome¡^

Branchio-Oto-Renal ¯g­Ô¸s
¡]BOR ¯g­Ô¸s¡^

Q87.89

Z    ¨ä¥L¥¼¤ÀÃþ©Î¤£©ú­ì¦]

Z1

01

Cockayne¤ó¯g­Ô¸s

Cockayne syndrome

Q87.1

 

02

¦­¦Ñ¯g

Hutchinson Gilford progeria syndrome

E34.8

 

03

¾v-¨x-¸z¯g­Ô¸s

Tricho-hepato-enteric syndrome

Q89.7

 

04

Stargardt's¤ó¯g

Stargardt's  disease

H35.50

 

05

Áô°Î©Ê¶À´³³¡¥¢¾i¯g

Occult Macular Dystrophy¡FOMD

H35.50

 

06

µÜ§B¤ó¥ý¤Ñ©Ê¶Âé¯g

Leber Congenital Amaurosis

H35.50

 

(¤T)   ¬y·P¬Ì­]±µºØ¶·ª¾

 

¬Ì­]¦¨¤À¤Î¯S©Ê

¬y·P¬Ì­]¬O¤£¬¡¤Æ¬Ì­]¡C¥Ñ©ó¬y·P¯f¬r±`±`µo¥ÍÅܲ§¡A©Ò¥H¥@¬É½Ã¥Í²Õ´¨C ¦~§¡·|ºÊ´ú¬y·P¯f¬rªº¬y¦æ¤ÎÅܲ§¡A¥H«ØÄ³¬Ì­]ªº¦¨¥÷¡C¥»­pµe¨Ï¥Î¨Ì¾Ú¥@¬É½Ã ¥Í²Õ´¨C¦~¹ï¥_¥b²y«ØÄ³»ù¼Æ¡]¤T»ù/¥|»ù¡^¤Î§Ü­ì¦¨¤À¤§¬y·P¬Ì­]¡A¨ä«OÅ@®Ä¤O »P°ê»Ú¦U°êª¬ªp¬Û¦P¡C¤T»ù¬y·P¬Ì­]¥]§t 3 ºØ¤£¬¡¤Æ¯f¬r®è¡A§Y 2 ºØ A «¬¡]H1N1 ¤Î H3N2¡^¤Î 1 ºØ B «¬¡]Victoria¡^¡A¥|»ù¬y·P¬Ì­]¥t·s¼W 1 ºØ B «¬¤£¬¡¤Æ¯f¬r®è¡]Yamagata¡^¡A¨Ã¨Ì·Ó¬Ì­]¨ì³f¶¶§Ç¨Ì§Ç´£¨Ñ¡C

 

±µºØ¾¯¶q¤Î¶¡¹j

6­Ó¤ë¥H¤W¨C¦¸±µºØ¾¯¶q¬O0.5mL¡]¦U¼tµP¾A¥Î¦~ÄÖ¤£¦P¡A¸Ô¨£¥é³æ¡u²£«~»¡©ú®Ñ¡v¡^¡C¥t¥~¡A¥¼º¡9·³¨àµ£¡A­Y¬Oªì¦¸±µºØ©u¸`©Ê¬y·P¬Ì­]¡AÀ³±µºØ2¾¯¡A2¾¯¶¡¹j4¶g¥H¤W¡A­Y¹L¥h´¿±µºØ¹L©u¸`©Ê¬y·P¬Ì­]¡]¤£½×1¾¯©Î2¾¯¡^¡A¤µ¦~±µºØ1¾¯§Y¥i¡C

9·³¥H¤W«h¤£½×¹L¥h¬O§_´¿±µºØ¹L©u¸`©Ê¬y·P¬Ì­]¡A³£¥u¶·±µºØ1¾¯¡C

 

«OÅ@®ÄªG

¬Ì­]ªº«OÅ@®ÄªG»Ýµø·í¦~¨Ï¥Îªº¬Ì­]®è¬O§_»P¹ê»Ú¬y¦æªº¯f¬r®è«¬§O¬Û²Å¡A¥H¤Î±µºØ¹ï¶Hªº¦~Ä֩Ψ­Å骬ªp¦Ó²§¡A¥­§¡¬ù¬°30~80%¡C¹ï18·³¥H¤W¦¨¤H¦]½T¶E¬y·P¦Ó¦í°|ªº«OÅ@¤O¬ù¦³41%¡A¤J¦í¥[Å@¯f©Ðªº¬y·P­«¯g«OÅ@¤O«h¥i¹F82%¡C6­Ó¤ë¦Ü¥¼º¡18·³¨àµ£«C¤Ö¦~±Ú¸s±µºØ¬y·P¬Ì­]¤§«OÅ@¤O»P¦¨¤H¬Û¥é¡C

 

­pµe¹ê¬I¹ï¶H

u  ©ö¨ü·P¬V¥B¥X²{ÄY­«¨Öµo¯gªº°ª¦MÀI¸s¡A¥]¬A50·³¥H¤W¦¨¤H¡B¦w¾i/¾iÅ@/ªø´Á·ÓÅUµ¥¾÷ºcªº¨ü·ÓÅUªÌ¡B¨u¨£¯e¯f±wªÌ¡Bº¡6­Ó¤ë¥H¤W¦Ü°ê¤p¤J¾Ç«e¥®¨à¡B­«¤j¶Ë¯f±wªÌ¡B°ª­·ÀIºC©Ê¯f¤H¡B¥¥°ü¤Î²£«á2¶g¤º°ü¤k¡C

u  ©ö¼ÉÅS¤Î¶Ç¬V¬y·Pµ¹°ª¦MÀI¸sªÌ¡A¥]¬A6­Ó¤ë¤ºÀ¦¨à¤§¤÷¥À¡BÂ卯¤u§@¤H­û¡B¦w¾i/¾iÅ@/ªø´Á·ÓÅUµ¥¾÷ºc©ÒÄݪº¤u§@¤H­û¡B½Ã¥Íµ¥³æ¦ìªº¨¾¬Ì¤H­û¡B°ê¤p¨ì°ª¤¤/¾¾Ç¥Í¡]§t¶i­×³¡»P¹Ò¥~»O®Õ¾Ç¥Í¡B¤Ö¦~ÁB¥¿¾Ç®Õ¤Î»²¨|°|¾Ç¥Í¡BÄÝ¡u¤¤³~¾Ç®Õ-¦b¶é±Ð¨|¡v©Ê½è¤§¨àµ£¤Î¤Ö¦~¦w¸m±Ð¾i¾÷ºc¾Ç¥Í¡A¥H¤Î¦Û¾Ç¾Ç¥Í¡^¤Î¥®¨à¶é¦«¨|¤H­û¤Î¦«¨|¾÷ºc±M·~¤H­û¡C

u  Âû¡BÀn¡BÃZ¡B½Þ¡B¤û¡B¦Ï¡B¤õÂû¡BÀk³¾µ¥¸V¯b¤§¾i´Þ¡B±O®_¡B¹B¿é¡B¬¡Åé³c½æµ¥¦æ·~ªº¤u§@¤H­û¡C

±µºØ¸T§Ò

¤@¡B¤wª¾¹ï¬Ì­]ªº¦¨¤À¦³¹L±ÓªÌ¡A¤£¤©±µºØ¡C

¤G¡B¹L¥hª`®g´¿¸gµo¥ÍÄY­«¤£¨}¤ÏÀ³ªÌ¡A¤£¤©±µºØ¡C

±µºØª`·N¨Æ¶µ

¤@¡Bµo¿N©Î¥¿±w¦³«æ©Ê¤¤­«¯e¯fªÌ¡A©y«Ý¯f±¡Ã­©w«á¦A±µºØ¡C

¤G¡B¥X¥Í¥¼º¡6­Ó¤ë¡A¦]µL¨Ï¥Î®Ä¯q¤Î¦w¥þ©Êµ¥Á{§É¸ê®Æ¡A¬G¤£¤©±µºØ¡C

¤T¡B¥ý«e±µºØ¥»¬Ì­]¤»¶g¤º´¿µo¥ÍGuillain-Barr Á¯g­Ô¸s¡]GBS¡^ªÌ¡A©y½ÐÂå®vµû¦ô¡C

¥|¡B¨ä¥L¸gÂå®vµû¦ô¤£¾A¦X±µºØªÌ¡A¤£¤©±µºØ¡C

±µºØ®É¶¡

¥Ñ©ó¨C¦~¬y¦æªº¬y·P¯f¬r¤£¤@©w¬Û¦P¡A¦]¦¹¡A²Å¦X±µºØ­pµe¹ê¬I¹ï¶HªÌ¡A¨C¦~§¡¶·­«·s±µºØ¡C±µºØ«á¦Ü¤Ö¬ù»Ý2¶gªº®É¶¡¥H²£¥Í«OÅ@¤O¡A¨ä«OÅ@®ÄªG¥i«ùÄò1¦~¡A±M®a«ØÄ³À³©ó¨C¦~9¤ë¤¤¦¯¥H«á¬I¥´¡A¦ýÀ³¾¨¶q¦b11¤ë¤U¦¯¤§«e§¹¦¨±µºØ¡A¥H¦]À³¨C¦~¹A¾ä¬K¸`«e«á¤Î2¡B3¤ëªº¬y·P¬y¦æ´Á¡C

¦w¥þ©Ê¤Î°Æ§@¥Î

¬y·P¬Ì­]¬O¥Ñ¦º¯f¬r»s¦¨ªº¤£¬¡¤Æ¬Ì­]¡A¦]¦¹¤£·|¦]¬°±µºØ¬y·P¬Ì­]¦Ó·P¬V¬y·P¡C

±µºØ«á¥i¯à·|¦³ª`®g³¡¦ì¯kµh¡B¬õ¸~¡A¤Ö¼Æªº¤H·|¦³¥þ¨­©Êªº»´·L¤ÏÀ³¡A¦pµo¿N¡BÀYµh¡B¦Ù¦×»Äµh¡Bäú¤ß¡B¥Ö½§·kÄo¡BëC³Â¯l©Î¬õ¯lµ¥¡A£¸¯ë·|¦bµo¥Í«á1¦Ü2¤Ñ¤º¦ÛµM«ì´_¡C©M¨ä¥L¥ô¦óÃÄ«~¤@¼Ë¡AÁöµM·¥¤Öµo¥Í¡A¦ý¬y·P¬Ì­]¤]¦³¥i¯à³y¦¨ÄY­«ªº°Æ§@¥Î¡A¦p¥ß§Y«¬¹L±Ó¤ÏÀ³¡A¬Æ¦Ü¹L±Ó©Ê¥ð§Jµ¥¤£¾A±¡ªp¡]Á{§Éªí²{¥]¬A©I§l§xÃø¡BÁn­µ¨F°×¡B®ð³Ý¡B²´·ú©Î¼L®B¸~µÈ¡BÀY©ü¡B¤ß¸õ¥[³tµ¥¡^¡A­Y¤£©¯µo¥Í¡A³q±`©ó±µºØ«á´X¤ÀÄÁ¦Ü´X¤p®É¤º§Y¥X²{¯gª¬¡C¨ä¥L´¿³Q¹s¬P³ø§i¹L¤§¤£¨}¨Æ¥ó¥]¬A¯«¸g¨t²Î¯gª¬¡]¦p¡GÁu¯«¸gÂOª¢¡BÃC­±¯«¸g³Â·ô¡B¼öµjÅË¡B¸£¯áÅ誢¡B¹ïºÙ©Ê¯«¸g³Â·ô¬°ªí²{ªºGBSµ¥¡^©M¦å²G¨t²Î¯gª¬¡]¦p¡G¼È®É©Ê¦å¤pªO§C¤U¡AÁ{§Éªí²{¥]¬A¥Ö½§¥X²{µµ´³©Î¥X¦åÂI¡B¥X¦å®É¤£©ö¤î¦åµ¥¡^¡C°£¤F1976¦~½Þ¬y·P¬Ì­]¡B2009¦~H1N1·s«¬¬y·P¬Ì­]»P³¡¤À©u¸`©Ê¬y·P¬Ì­]¸g¬y¦æ¯f¾Ç¬ã¨sÃÒ¹ê»PGBS¥i¯à¬ÛÃö¥~¡A¨ä¥L¤Ö¦³½T¤Á²Î­p¼Æ¾ÚÃÒ©ú»P±µºØ¬y·P¬Ì­]¦³Ãö¡C¦¹¥~¡A²{¦³¬ã¨sµ²ªG»P¥@¬É½Ã¥Í²Õ´³ø§i§¡Åã¥Ü¡A¥¥°ü±µºØ¤£¬¡¤Æ¬y·P¬Ì­]¡A¨Ã¥¼¼W¥[§³®W¤Î­L¨à¤£¨}¨Æ¥ó¤§­·ÀI¡C

¥Ø«e¬ã¨sµo²{¡AÂû³J¹L±ÓªÌ±µºØÂû­F­L»sµ{¤§¬y·P¬Ì­]¨Ã¤£·|¼vÅT¹L±Ó¤ÏÀ³µo¥Í²v¡A°ê»Ú¤W¬Ò«ØÄ³Âû³J¹L±ÓªÌ¥i¦w¤ß±µºØ¬y·P¬Ì­]¡C

±µºØ«áª`·N¨Æ¶µ

¤@¡B±µºØ¬Ì­]«á¦³·¥§Cªº¥i¯à©Êµo¥Í¥ß§Y«¬¹L±Ó¤ÏÀ³¡AÄY­«®É¥i¯à¾É­P¹L±Ó©Ê¡C

¬°¤F¯à¦b¨Æ¥óµo¥Í«á¥ß§Y¶i¦æÂåÀø¡A±µºØ«áÀ³©ó±µºØ³æ¦ì©Îªþªñµy°µ¥ð®§¡A¨ÃÆ[¹î15¤ÀÄÁ¡AÂ÷¶}«á½Ð¦Û§Ú±K¤ÁÆ[¹î15¤ÀÄÁ¡C

¤G¡B¨Ï¥Î§Ü¦å¤pªO©Î§Ü¾®¦åÃĪ«©Î¾®¦å¥\¯à²§±`ªÌ¬I¥´«á©óª`®g³¡¦ì¥[À£¦Ü¤Ö2¤ÀÄÁ¡A¨ÃÆ[¹î¬O§_¤´¦³¥X¦å©Î¦å¸~±¡§Î¡C

¤T¡B±µºØ«á¦p¦³«ùÄòµo¿N(¶W¹L48¤p®É)¡B®É¡^¡B·NÃѩΦ欰§ïÅÜ¡B©I§l§xÃø¡B¤ß¸õ

¥[³tµ¥²§±`ª¬ªp¡A¦p¦³¤£¾A¡AÀ³¾¨³t´NÂå¡A§iª¾Âå®v¬ÛÃö¯gª¬¡B¯gª¬µo¥Í®É¶¡¡B ¬Ì­]±µºØ®É¶¡¡A¥H°µ¬°¶EÂ_°Ñ¦Ò¡A¨Ã³q³ø·í¦a½Ã¥Í§½©Î¯e¯fºÞ¨î¸p¡C

¥|¡B§¹¦¨¬Ì­]±µºØ«á¡AÁö¥i­°§C·P¬V¬y·Pªº¾÷²v¡A¦ý¤´¦³¥i¯à¿©±w¨ä¥L«D¬y·P¯f¬r©Ò¤Þ°_ªº©I§l¹D·P¬V¡A½Ð¥Á²³Áٻݪ`­««O°·»P¦UºØ¨¾¬Ì±¹¬I¡A¥HºûÅ@¨­Åé°·±d¡C